|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ali Z, Deng Y and Ma C: Progress of
research in gastric cancer. J Nanosci Nanotechnol. 12:8241–8248.
2012. View Article : Google Scholar
|
|
3
|
Berx G and van Roy F: Involvement of
members of the cadherin superfamily in cancer. Cold Spring Harb
Perspect Biol. 1:a0031292009. View Article : Google Scholar
|
|
4
|
Makrilia N, Kollias A, Manolopoulos L and
Syrigos K: Cell adhesion molecules: role and clinical significance
in cancer. Cancer Invest. 27:1023–1037. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Philippova M, Joshi MB, Kyriakakis E,
Pfaff D, Erne P and Resink TJ: A guide and guard: the many faces of
T-cadherin. Cell Signal. 21:1035–1044. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chan DW, Lee JM, Chan PC and Ng IO:
Genetic and epigenetic inactivation of T-cadherin in human
hepatocellular carcinoma cells. Int J Cancer. 123:1043–1052. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ren JZ and Huo JR: Correlation between
T-cadherin gene expression and aberrant methylation of T-cadherin
promoter in human colon carcinoma cells. Med Oncol. 29:915–918.
2012. View Article : Google Scholar
|
|
8
|
Adachi Y, Takeuchi T, Nagayama T and
Furihata M: T-cadherin modulates tumor-associated molecules in
gallbladder cancer cells. Cancer Invest. 28:120–126. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Duan XS, Lu J, Ge ZH, Xing EH, Lu HT and
Sun LX: Effects of T-cadherin expression on B16F10 melanoma cells.
Oncol Lett. 5:1205–1210. 2013.PubMed/NCBI
|
|
10
|
Kim DS, Kim MJ, Lee JY, Kim YZ, Kim EJ and
Park JY: Aberrant methylation of E-cadherin and H-cadherin genes in
nonsmall cell lung cancer and its relation to clinicopathologic
features. Cancer. 110:2785–2792. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Toyooka KO, Toyooka S, Virmani AK, et al:
Loss of expression and aberrant methylation of the CDH13
(H-cadherin) gene in breast and lung carcinomas. Cancer Res.
61:4556–4560. 2001.PubMed/NCBI
|
|
12
|
Tang Y, Dai Y and Huo J: Decreased
expression of T-cadherin is associated with gastric cancer
prognosis. Hepatogastroenterology. 59:1294–1298. 2012.PubMed/NCBI
|
|
13
|
Folkman J: Role of angiogenesis in tumor
growth and metastasis. Semin Oncol. 29:15–18. 2002. View Article : Google Scholar
|
|
14
|
Saharinen P, Eklund L, Pulkki K, Bono P
and Alitalo K: VEGF and angiopoietin signaling in tumor
angiogenesis and metastasis. Trends Mol Med. 17:347–362. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Iurlova EI, Rubina KA, Sysoeva V, et al:
T-cadherin suppresses the cell proliferation of mouse melanoma
B16F10 and tumor angiogenesis in the model of the chorioallantoic
membrane. Ontogenez. 41:261–270. 2010.In Russian. PubMed/NCBI
|
|
16
|
Hebbard LW, Garlatti M, Young LJ, Cardiff
RD, Oshima RG and Ranscht B: T-cadherin supports angiogenesis and
adiponectin association with the vasculature in a mouse mammary
tumor model. Cancer Res. 68:1407–1416. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang J, Zhou Y and Jiang K: Evaluation of
the seventh AJCC TNM staging system for gastric cancer: a
meta-analysis of cohort studies. Tumour Biol. 35:8525–8532. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2-(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
19
|
Okegawa T, Pong RC, Li Y and Hsieh JT: The
role of cell adhesion molecule in cancer progression and its
application in cancer therapy. Acta Biochim Pol. 51:445–457.
2004.PubMed/NCBI
|
|
20
|
Zigler M, Dobroff AS and Bar-Eli M: Cell
adhesion: implication in tumor progression. Minerva Med.
101:149–162. 2010.PubMed/NCBI
|
|
21
|
Auerkari EI: Methylation of tumor
suppressor genes p16 (INK4a), p27 (Kip1) and E-cadherin in
carcinogenesis. Oral Oncol. 42:5–13. 2006. View Article : Google Scholar
|
|
22
|
Albergaria A, Ribeiro AS, Vieira AF, et
al: P-cadherin role in normal breast development and cancer. Int J
Dev Biol. 55:811–822. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mariotti A, Perotti A, Sessa C and Rüegg
C: N-cadherin as a therapeutic target in cancer. Expert Opin
Investig Drugs. 16:451–465. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Joshi MB, Ivanov D, Philippova M, Erne P
and Resink TJ: Integrin-linked kinase is an essential mediator for
T-cadherin-dependent signaling via Akt and GSK3beta in endothelial
cells. FASEB J. 21:3083–3095. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hibi K, Kodera Y, Ito K, Akiyama S and
Nakao A: Methylation pattern of CDH13 gene in digestive tract
cancers. Br J Cancer. 91:1139–1142. 2004.PubMed/NCBI
|
|
26
|
Yan Q, Zhang ZF, Chen XP, et al: Reduced
T-cadherin expression and promoter methylation are associated with
the development and progression of hepatocellular carcinoma. Int J
Oncol. 32:1057–1063. 2008.PubMed/NCBI
|
|
27
|
Philippova M, Pfaff D, Kyriakakis E, et
al: T-cadherin loss promotes experimental metastasis of squamous
cell carcinoma. Eur J Cancer. 49:2048–2058. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Welti J, Loges S, Dimmeler S and Carmeliet
P: Recent molecular discoveries in angiogenesis and antiangiogenic
therapies in cancer. J Clin Invest. 123:3190–3200. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Liu W, Xu J, Wang M, Wang Q, Bi Y and Han
M: Tumor-derived vascular endothelial growth factor (VEGF)-a
facilitates tumor metastasis through the VEGF-VEGFR1 signaling
pathway. Int J Oncol. 39:1213–1220. 2011.PubMed/NCBI
|
|
30
|
Lin YL, Liu XQ, Li WP, Sun G and Zhang CT:
Promoter methylation of H-cadherin is a potential biomarker in
patients with bladder transitional cell carcinoma. Int Urol
Nephrol. 44:111–117. 2012. View Article : Google Scholar
|
|
31
|
La Torre G, Chiaradia G, Gianfagna F, et
al: Smoking status and gastric cancer risk: an updated
meta-analysis of case-control studies published in the past ten
years. Tumori. 95:13–22. 2009.PubMed/NCBI
|
|
32
|
Duell EJ, Travier N, Lujan-Barroso L, et
al: Alcohol consumption and gastric cancer risk in the European
Prospective Investigation into Cancer and Nutrition (EPIC) cohort.
Am J Clin Nutr. 94:1266–1275. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kato M and Asaka M: Recent knowledge of
the relationship between Helicobacter pylori and gastric cancer and
recent progress of gastroendoscopic diagnosis and treatment for
gastric cancer. Jpn J Clin Oncol. 40:828–837. 2010. View Article : Google Scholar : PubMed/NCBI
|
